Fig. 1 · Structure
Documents & Downloads
Efineptakin alfa
rhIL-7-hyFc
Efineptakin alfa is a long-acting recombinant form of human IL-7, functioning primarily through the rhIL-7-hyFc mechanism. This reagent enhances the proliferation and survival of CD4+ and CD8+ T cells in human and mouse models. It is particularly valuable for research into glioblastoma and the modulation of immune responses in various therapeutic contexts.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 2026634-47-7 |
| Applications | rhIL-7-hyFc |
| Molecular Weight | 90.96 kDa |
| Synonyms | NT-17 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.